Clinical Center of Vojvodina

Vojvodina 21000

0 studies enrolling now · 2 studies all time

What they study most

Crohn Disease, Lupus Erythematosus, Systemic

Studies at this site

• Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year — Completed
• A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus — Stopped early